177 related articles for article (PubMed ID: 25422294)
1. Association analysis between the polymorphisms of HSD17B5 and HSD17B6 and risk of polycystic ovary syndrome in Chinese population.
Ju R; Wu W; Fei J; Qin Y; Tang Q; Wu D; Xia Y; Wu J; Wang X
Eur J Endocrinol; 2015 Mar; 172(3):227-33. PubMed ID: 25422294
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms of the HSD17B6 and HSD17B5 genes in Chinese women with polycystic ovary syndrome.
Ke L; Che YN; Cao YX; Wu XK; Hu YL; Sun HX; Liang FJ; Sun J; Yi L; Wang Y
J Womens Health (Larchmt); 2010 Dec; 19(12):2227-32. PubMed ID: 21039282
[TBL] [Abstract][Full Text] [Related]
3. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
[TBL] [Abstract][Full Text] [Related]
4. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
Goodarzi MO; Jones MR; Antoine HJ; Pall M; Chen YD; Azziz R
J Clin Endocrinol Metab; 2008 Jan; 93(1):300-3. PubMed ID: 17940109
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism in HSD17B6 is associated with key features of polycystic ovary syndrome.
Jones MR; Italiano L; Wilson SG; Mullin BH; Mead R; Dudbridge F; Watts GF; Stuckey BG
Fertil Steril; 2006 Nov; 86(5):1438-46. PubMed ID: 17070195
[TBL] [Abstract][Full Text] [Related]
6. Association of the 17-hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) with hyperandrogenemia in polycystic ovary syndrome (PCOS).
Marioli DJ; Saltamavros AD; Vervita V; Koika V; Adonakis G; Decavalas G; Markou KB; Georgopoulos NA
Fertil Steril; 2009 Aug; 92(2):648-52. PubMed ID: 18692800
[TBL] [Abstract][Full Text] [Related]
7. Screening of a panel of steroid-related genes showed polymorphisms of aromatase genes confer susceptibility to advanced stage endometriosis in the Taiwanese Han population.
Wu CH; Yang JG; Chang YJ; Hsu CC; Kuo PL
Taiwan J Obstet Gynecol; 2013 Dec; 52(4):485-92. PubMed ID: 24411031
[TBL] [Abstract][Full Text] [Related]
8. Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population.
Ju R; Wu W; Tang Q; Wu D; Xia Y; Wu J; Wang X
PLoS One; 2015; 10(10):e0140326. PubMed ID: 26452272
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between common polymorphisms in the 17beta-hydroxysteroid dehydrogenase type V gene (HSD17B5) and precocious pubarche.
Petry CJ; Ong KK; Wingate DL; de Zegher F; Ibáñez L; Dunger DB
J Steroid Biochem Mol Biol; 2007; 105(1-5):176-80. PubMed ID: 17583494
[TBL] [Abstract][Full Text] [Related]
10. 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Maier PS; Mattiello SS; Lages L; Spritzer PM
Gynecol Endocrinol; 2012 Aug; 28(8):606-10. PubMed ID: 22329763
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and haplotypes of the TGF-β1 gene are associated with risk of polycystic ovary syndrome in Chinese Han women.
Yang J; Zhong T; Xiao G; Chen Y; Liu J; Xia C; Du H; Kang X; Lin Y; Guan R; Yan P; Xiao J
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():1-7. PubMed ID: 25594618
[TBL] [Abstract][Full Text] [Related]
12. Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women.
Ha L; Shi Y; Zhao J; Li T; Chen ZJ
PLoS One; 2015; 10(5):e0126505. PubMed ID: 25978310
[TBL] [Abstract][Full Text] [Related]
13. Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome.
Zhang R; Liu Q; Liu H; Bai H; Zhang Y; Guan L; Fan P
Lipids Health Dis; 2018 Apr; 17(1):77. PubMed ID: 29636060
[TBL] [Abstract][Full Text] [Related]
14. Quality of life effects of androgen deprivation therapy in a prostate cancer cohort in New Zealand: can we minimize effects using a stratification based on the aldo-keto reductase family 1, member C3 rs12529 gene polymorphism?
Karunasinghe N; Zhu Y; Han DY; Lange K; Zhu S; Wang A; Ellett S; Masters J; Goudie M; Keogh J; Benjamin B; Holmes M; Ferguson LR
BMC Urol; 2016 Aug; 16(1):48. PubMed ID: 27485119
[TBL] [Abstract][Full Text] [Related]
15. [Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome].
Qi Q; Zhang H; Yu M; Wang X; Wang Z; Xu L; Wang J; Mu H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Jun; 32(3):400-4. PubMed ID: 26037361
[TBL] [Abstract][Full Text] [Related]
16. Association of CYP17A1 gene -34T/C polymorphism with polycystic ovary syndrome in Han Chinese population.
Li L; Gu ZP; Bo QM; Wang D; Yang XS; Cai GH
Gynecol Endocrinol; 2015 Jan; 31(1):40-3. PubMed ID: 25208301
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of methylenetetrahydrofolate reductase is associated with insulin resistance in Egyptian women with polycystic ovary syndrome.
Nsrallah AA; Abd-El Fatah AH; Ahmed HS
J Gene Med; 2019 Apr; 21(4):e3076. PubMed ID: 30743312
[TBL] [Abstract][Full Text] [Related]
18. Verification of a ZBTB16 variant in polycystic ovary syndrome patients.
Yang J; Zhao R; Li L; Li G; Yang P; Ma J; Zhao S; Zhao H
Reprod Biomed Online; 2020 Oct; 41(4):724-728. PubMed ID: 32773339
[TBL] [Abstract][Full Text] [Related]
19. Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women.
Liu Q; Liu H; Bai H; Huang W; Zhang R; Tan J; Guan L; Fan P
J Endocrinol Invest; 2019 Aug; 42(8):909-921. PubMed ID: 30607774
[TBL] [Abstract][Full Text] [Related]
20. Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women.
Zhang CW; Zhang XL; Xia YJ; Cao YX; Wang WJ; Xu P; Che YN; Wu XK; Yi L; Gao Q; Wang Y
Mol Biol Rep; 2012 Aug; 39(8):8379-85. PubMed ID: 22699877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
